Análisis de sangre para mal de Alzheimer sale a venta sin aprobación de FDA


St. Louis-based C2N Diagnostics has released a blood test that it says can detect Alzheimer’s disease. The test is not yet FDA approved, and is not covered by insurance, costing up to $1,250.

Fuente: Youtube